# A Study to Compare Efficacy and Safety of DRT VS CRT Plus Surgery in Patients Who Achieved CCR for Esophageal Cancer

> **NCT03708042** · PHASE3 · UNKNOWN · sponsor: **Tianjin Medical University Cancer Institute and Hospital** · enrollment: 220 (estimated)

## Conditions studied

- Stage II Esophageal Cancer
- Stage III Esophageal Cancer

## Interventions

- **COMBINATION_PRODUCT:** Definitive Radiochemotherapy
- **COMBINATION_PRODUCT:** Neoadjuvant Radiochemotherapy

## Key facts

- **NCT ID:** NCT03708042
- **Lead sponsor:** Tianjin Medical University Cancer Institute and Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-01
- **Primary completion:** 2021-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2018-10-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03708042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03708042, "A Study to Compare Efficacy and Safety of DRT VS CRT Plus Surgery in Patients Who Achieved CCR for Esophageal Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03708042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*